Scientific Program
It is based on the local time of Seoul, Korea. (UTC/ GMT +9:00)
* [KOR] = Sessions in Korean Updated as of October 10
Thursday, November 10
Waun Ki Hong Memorial Lecture
Date & Time | 11/10(Thu) 10:40-11:20 | Place | Crystal Ballroom |
---|
- ·
-
Searching for somatic mutations - one cell at a time
Peter J. Park (Harvard Medical School, Boston, MA, USA)
Session 1 : Single-cell transcriptome and cancer biology
Date & Time | 11/10(Thu) 08:40-10:20 | Place | Crystal Ballroom |
---|
- ·
-
Interrogating the surfaceome of pancreatic cancer subtypes
Tobiloba E. Oni (Whitehead Institute for Biomedical Research, Cambridge, MA, USA)
- ·
-
Single-cell analysis reveals recurring programs in cancer microenvironment
Jong-Eun Park (Korea Advanced Institute of Science and Technology, Korea)
- ·
-
Examining cell state transitions induced by cancer therapies using single-cell RNA sequencing
Luciane T. Kagohara (Johns Hopkins University, Baltimore, MD, USA)
- ·
-
Understanding responses to immunotherapy using single cell transcriptomes
Jeeyun Lee (Sungkyunkwan University School of Medicine, Korea)
Session 2 : Artificial intelligence and computational biology approach
Date & Time | 11/10(Thu) 12:20-14:00 | Place | Crystal Ballroom |
---|
- ·
-
Genetic interaction mapping for discovery of synthetic lethal drug targets in cancer
Alice Berger (Fred Hutchinson Cancer Center, Seattle, WA, USA)
- ·
-
AI-based cancer screening using liquid biopsy
Eun-Hae Cho (GC Genome, Korea)
- ·
-
3D genome reorganization in cancer
Martin Aryee (Dana Farber Cancer Institute, Boston, MA, USA)
- ·
-
AI-powered biomarker development to predict the clinical outcomes of immuno-oncology agents
Sehhoon Park (Sungkyunkwan University School of Medicine, Korea)
Session 3 : Functional genomics and proteomics
Date & Time | 11/10(Thu) 14:20-16:00 | Place | Crystal Ballroom |
---|
- ·
-
Functional genomics identified CHK1 as a promising target in homologous recombination proficient high grade serous ovarian cancer
Christina M. Annunziata (National Cancer Institute in Bethesda, MD, USA)
- ·
-
Metabolic dysregulation leads to better response to cancer immunotherapy
Joo Sang Lee (Sungkyunkwan University School of Medicine, Korea)
- ·
-
Loss of nuclear alpha-catenin leads to ATR activation and contributes to poor outcome and chemoresistance in triple negative breast cancer
John D. Carpten (Keck School of Medicine of USC, Los Angeles, CA, USA)
- ·
-
Functional assessment of patient-derived mutations using CRISPR-Cas system
Yongsub Kim (University of Ulsan College of Medicine, Korea)
Session 4 : Novel epigenetic therapeutic strategies
Date & Time | 11/10(Thu) 16:20-18:00 | Place | Crystal Ballroom |
---|
- ·
-
Combining demethylating agents with immune checkpoint inhibition to treat refractory malignancies: Promise and pitfalls
Casey O’Connell (Keck School of Medicine of USC, Los Angeles, CA, USA)
- ·
-
Cancer reversion
Kwang-Hyun Cho (Korea Advanced Institute of Science and Technology, Korea)
- ·
-
Epigenetic changes: Targets and biomarkers
James G. Herman (UPMC Hillman Cancer Center, Pittsburgh, PA, USA)
- ·
-
Epigenetic code in health and diseases
Sung Hee Baek (Seoul National University College of Natural Sciences, Korea)
Luncheon Symposium 1 – Boryung [KOR]
Date & Time | 11/10(Thu) 11:20-12:00 | Place | Crystal Ballroom |
---|
- ·
-
Lurbinectedin for the treatment of small cell lung cancer
Bong-Seog Kim (Boryung Co. Ltd., Korea)
Luncheon Symposium 2 – ONO/BMS
Date & Time | 11/10(Thu) 11:20-12:00 | Place | Emerald Room |
---|
- ·
-
The optimal option with long-term survival and tolerability in advanced (1L) GC/GEJ EAC and melanoma: nivolumab based therapies
Wonyoung Choi (National Cancer Center, Korea)
Luncheon Symposium 3 - Roche [KOR]
Date & Time | 11/10(Thu) 11:20-12:00 | Place | Sapphire Ballroom |
---|
- ·
-
Demonstrated efficacy and long term safety about Bevacizumab in CRC
Ho Jung An (The Catholic University of Korea, St. Vincent’s Hospital, Korea)
Friday, November 11
Session 5 : T-cell redirected therapies for cancer
Date & Time | 11/11(Fri) 08:30-10:10 | Place | Crystal Ballroom |
---|
- ·
-
Updated results of a phase I trial of PSMA-targeting TGFβ-insensitive armored CAR T cells in metastatic castration-resistant prostate cancer
Naomi B. Haas (Penn Medicine Abramson Cancer Center, Philadelphia, PA, USA)
- ·
-
A novel mechanism of targeting both LAG-3 and PD-L1 with a bispecific antibody
Yoon Park (Korea Institute of Science and Technology, Korea)
- ·
-
CAR T-cell based combination immunotherapy for solid tumors
Prasad S. Adusumilli (Memorial Sloan Kettering Cancer Center, New York, NY, USA)
- ·
-
Regulation of T cell immunity in lymph node and tumor
Sang-Jun Ha (Yonsei University College of Life Science and Biotechnology, Korea)
Session 6 : Precision vaccination for cancer treatment
Date & Time | 11/11(Fri) 10:30-12:10 | Place | Crystal Ballroom |
---|
- ·
-
Vaccines targeting mutant KRAS neoantigens in combination with immune checkpoint blockade
Neeha Zaidi (The Johns Hopkins Hospital, Baltimore, MD, USA)
- ·
-
Determinants of neoantigen validity in cancer immunotherapy
Kwoneel Kim (Kyung Hee University College of Science, Korea)
- ·
-
Identification and characterization tumor-reactive T cells in malignant tumors through TCR analysis
Bo Li (UT Southwestern Medical Center, Dallas, TX, USA)
- ·
-
Characterization of tumor antigen-specific T cells in blood and tumors
Eui-Cheol Shin (Korea Advanced Institute of Science and Technology, Korea)
Luncheon Symposium 4 – Lilly [KOR]
Date & Time | 11/11(Fri) 12:20-13:00 | Place | Crystal Ballroom |
---|
- ·
-
Take hope further with abemaciclib for patients with HR+, HER2- breast cancer
Kyong Hwa Park (Korea University College of Medicine, Korea)
Luncheon Symposium 5 – MSD [KOR]
Date & Time | 11/11(Fri) 12:20-13:00 | Place | Emerald Room |
---|
- ·
-
Let 1L esophageal cancer patients start a whole new world with Pembrolizumab
In-Ho Kim (The Catholic University of Korea College of Medicine, Korea)
KCA Symposium 1 : Novel cancer therapeutics [KOR]
Date & Time | 11/11(Fri) 13:20-15:00 | Place | Crystal Ballroom |
---|
- ·
-
PROTAC drugs in oncology: Concepts and cases
Hwa Jin Lee (UPPThera, inc, Korea)
- ·
-
Novel radiopharmaceutical therapies
Joo Hyun O (The Catholic University of Korea College of Medicine, Korea)
- ·
-
Cancer nanotheranostics
Hyung-Jun Im (Seoul National University Graduate School of Convergence Science and Technology, Korea)
- ·
-
New therapeutic modalities for the intractable cancers
Jung Min Lee (Handong University School of Life Sciences, Korea)
KCA Symposium 2 : Precision radiotherapy with response prediction and real-time adaptation [KOR]
Date & Time | 11/11(Fri) 13:20-15:00 | Place | Emerald Room |
---|
- ·
-
Auto-contouring and online adaptive radiotherapy
Jin Sung Kim (Yonsei University College of Medicine, Korea)
- ·
-
MRI-guided radiotherapy and adaptation
Jun Won Kim (Yonsei University College of Medicine, Korea)
- ·
-
Genomic biomarker of radiotherapy and response prediction
Bum-Sup Jang (Seoul National University College of Medicine, Korea)
- ·
-
Response prediction of radiotherapy with radiomics
Jaeseung Shin (Samsung Medical Center, Korea)
KCA Symposium 3 : Diagnostic and therapeutic challenges in precision oncology [KOR]
Date & Time | 11/11(Fri) 15:20-17:00 | Place | Crystal Ballroom |
---|
- ·
-
Minimal residual disease in colorectal cancer
Sae-Won Han (Seoul National University College of Medicine, Korea)
- ·
-
Spatial transcriptomics of gastric cancers
Tae-Min Kim (The Catholic University of Korea College of Medicine, Korea)
- ·
-
The telomere maintenance mechanism spectrum and its dynamics in gliomas
Chul-Kee Park (Seoul National University College of Medicine, Korea)
- ·
-
Precision medicine-based platform trial: Innovative clinical trial design in the era of precision medicine
Yeon Hee Park (Sungkyunkwan University School of Medicine, Korea)
KCA Symposium 4 : Surgical oncology for advanced solid tumors [KOR]
Date & Time | 11/11(Fri) 15:20-17:00 | Place | Emerald Room |
---|
- ·
-
Complete cytoreductive surgery for resetting PARPi or PD-1i-Resistant recurrent ovarian, fallopian tubal, peritoneal carcinoma
Myong Cheol Lim (National Cancer Center, Korea)
- ·
-
Role of intraperitoneal chemotherapy for gastric cancer with peritoneal metastasis
Jong-Han Kim (Korea University College of Medicine, Korea)
- ·
-
Conversion surgery in unresectable pancreatic cancer
Jin-Young Jang (Seoul National University College of Medicine, Korea)
- ·
-
Surgical treatment for retroperitoneal sarcoma
Kyo Won Lee (Sungkyunkwan University School of Medicine, Korea)